Paolo Carfagna

454 total citations
24 papers, 331 citations indexed

About

Paolo Carfagna is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Paolo Carfagna has authored 24 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 11 papers in Infectious Diseases and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Paolo Carfagna's work include Infective Endocarditis Diagnosis and Management (8 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Streptococcal Infections and Treatments (5 papers). Paolo Carfagna is often cited by papers focused on Infective Endocarditis Diagnosis and Management (8 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Streptococcal Infections and Treatments (5 papers). Paolo Carfagna collaborates with scholars based in Italy, Spain and Myanmar. Paolo Carfagna's co-authors include Mario Venditti, Marco Falcone, Alessandro Russo, Pietro Serra, Roberta Caccese, Paola Goldoni, Antonio Vena, Fabrizio Taglietti, Simone Giuliano and Pietro Martino and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Clinical Microbiology and Infection and International Journal of Antimicrobial Agents.

In The Last Decade

Paolo Carfagna

22 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paolo Carfagna Italy 11 219 181 74 46 45 24 331
V. Baños Spain 10 150 0.7× 187 1.0× 78 1.1× 47 1.0× 24 0.5× 23 401
Elena Bereciartúa Spain 8 259 1.2× 159 0.9× 80 1.1× 40 0.9× 39 0.9× 18 349
Joan Hoppe‐Bauer United States 9 235 1.1× 261 1.4× 116 1.6× 32 0.7× 34 0.8× 13 454
Andrew A. Mahony Australia 10 151 0.7× 148 0.8× 73 1.0× 29 0.6× 40 0.9× 20 339
Linda Graviss United States 9 116 0.5× 103 0.6× 65 0.9× 36 0.8× 21 0.5× 14 305
A Moreno-Martínez Spain 6 215 1.0× 218 1.2× 185 2.5× 28 0.6× 83 1.8× 9 368
G J Malanoski United States 6 196 0.9× 152 0.8× 128 1.7× 83 1.8× 68 1.5× 8 389
Adel Ben Ali France 6 142 0.6× 109 0.6× 82 1.1× 22 0.5× 25 0.6× 7 273
José David Simonin López Spain 7 133 0.6× 170 0.9× 81 1.1× 24 0.5× 26 0.6× 9 332
Jeffrey Tarrand United States 9 217 1.0× 193 1.1× 107 1.4× 45 1.0× 32 0.7× 12 378

Countries citing papers authored by Paolo Carfagna

Since Specialization
Citations

This map shows the geographic impact of Paolo Carfagna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Carfagna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Carfagna more than expected).

Fields of papers citing papers by Paolo Carfagna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Carfagna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Carfagna. The network helps show where Paolo Carfagna may publish in the future.

Co-authorship network of co-authors of Paolo Carfagna

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Carfagna. A scholar is included among the top collaborators of Paolo Carfagna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Carfagna. Paolo Carfagna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coscarella, Carlo, et al.. (2024). Urgent or Emergent Endovascular Aortic Repair of Infective Aortitis. Journal of Clinical Medicine. 13(16). 4669–4669.
2.
Falcone, Marco, Giusy Tiseo, Giammarco Raponi, et al.. (2018). Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes. Clinical Microbiology and Infection. 25(4). 474–480. 16 indexed citations
3.
Russo, Alessandro, Marco Falcone, Massimo Fantoni, et al.. (2015). Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection. Clinical Microbiology and Infection. 21(5). 493.e1–493.e4. 25 indexed citations
4.
Falcone, Marco, Antonio Vena, Maria Lina Mezzatesta, et al.. (2014). Role of empirical and targeted therapy in hospitalized patients with bloodstream infections caused by ESBL-producing Enterobacteriaceae.. PubMed. 26(4). 293–304. 14 indexed citations
5.
Grieco, Stefania, Simone Giuliano, Marco Falcone, et al.. (2014). A cluster of fulminant Clostridium difficile colitis in an intensive care unit in Italy. Infection. 42(3). 585–589. 9 indexed citations
6.
Caccese, Roberta, et al.. (2012). Candidal thrombophlebitis of central veins: case report and review. Medical Mycology. 50(3). 299–304. 12 indexed citations
7.
Giuliano, Simone, Roberta Caccese, Paolo Carfagna, et al.. (2012). Endocarditis caused by nutritionally variant streptococci: a case report and literature review.. PubMed. 20(2). 67–74. 38 indexed citations
8.
Giordano, Alessandra, Alessia Bertini, Laura Villa, et al.. (2007). Outbreak of Acinetobacter baumannii Producing the Carbapenem-Hydrolyzing Oxacillinase OXA-58 in Rome, Italy. Microbial Drug Resistance. 13(1). 37–43. 18 indexed citations
9.
Venditti, Mario, Marco Falcone, Alessandra Micozzi, et al.. (2003). Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study.. PubMed. 88(8). 923–30. 47 indexed citations
10.
Falcone, Marco, Paolo Carfagna, Marco Cassone, et al.. (2002). [Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis].. PubMed. 17(3). 166–72. 8 indexed citations
11.
Onorati, Paolo, et al.. (2001). CD4+ T-lymphocytopenia and Pneumocystis carinii pneumonia in a patient with miliary tuberculosis. European Journal of Internal Medicine. 12(2). 134–136. 8 indexed citations
12.
Carfagna, Paolo, et al.. (2001). Arthritis as a rare side effect of phenytoin therapy. European Journal of Internal Medicine. 12(5). 448–450. 1 indexed citations
13.
Contini, Carlo, et al.. (2001). Plasminogen Activator Production in a Rat Model of Pneumocystis carinii Pneumonia. Microbiology and Immunology. 45(8). 605–611. 4 indexed citations
14.
Carfagna, Paolo, et al.. (2000). Prosthetic Biologic Valve Endocarditis Caused by a Vancomycin-Resistant (vanA)Enterococcus faecalis:Case Report. Journal of Chemotherapy. 12(5). 416–420. 6 indexed citations
15.
Carfagna, Paolo, et al.. (2000). Difficulties in the diagnosis of primary cardiac lymphomas.. PubMed. 85(7). 770–2. 6 indexed citations
16.
Carfagna, Paolo, et al.. (2000). Cerebral abscesses due to methicillin-resistant Staphylococcus aureus complicating stroke. European Journal of Internal Medicine. 11(1). 51–54.
17.
Carfagna, Paolo, et al.. (1998). [Systemic Salmonella arizonae infections in patients with a deficiency of cell-mediated immunity. A report of 2 cases and a review of the literature].. PubMed. 89(12). 632–6. 1 indexed citations
18.
Baiocchi, P, Manlio Galiè, C. Santini, et al.. (1998). In VitroSusceptibility ofStaphylococcus aureusIsolated from Blood to Currently Used Antistaphylococcal Drugs. Journal of Chemotherapy. 10(1). 25–28. 7 indexed citations
19.
Baiocchi, P, et al.. (1996). Changes in susceptibilities to teicoplanin, vancomycin and other antibiotics among Staphylococcus aureus isolates in a tertiary-care University hospital. International Journal of Antimicrobial Agents. 7(2). 93–96. 10 indexed citations
20.
Venditti, Mario, Paolo Carfagna, Alessandro Capone, et al.. (1996). STAPHYLOCOCCUS AUREUS MEININGITIS IN NEUROSURGERY ADULT PATIENTS. Infectious Diseases in Clinical Practice. 5(5). 325–330. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Baños Breakdown of academic impact, for papers by Elena Bereciartúa Breakdown of academic impact, for papers by Joan Hoppe‐Bauer Breakdown of academic impact, for papers by Andrew A. Mahony Breakdown of academic impact, for papers by Linda Graviss Breakdown of academic impact, for papers by A Moreno-Martínez Breakdown of academic impact, for papers by G J Malanoski Breakdown of academic impact, for papers by Adel Ben Ali Breakdown of academic impact, for papers by José David Simonin López Breakdown of academic impact, for papers by Jeffrey Tarrand
Rankless by CCL
2026